Quest for the artificial pancreas: Combining technology with treatment

IEEE Engineering in Medicine and Biology Magazine

Volumn 29, Issue 2, 2010, Pages 53-62

  Harvey, Rebecca A ^a   Wang, Youqing ^b   Grosman, Benyamin ^a   Percival, Matthew W ^a   Bevier, Wendy ^b   Finan, Daniel A ^c   Zisser, Howard ^b   Seborg, Dale S ^d   Jovanoviĉ, Lois ^b   Doyle III, Francis J ^e   Dassau, Eyal ^e  

^a Santa Barbara   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; BLOOD GLUCOSE; BLOOD GLUCOSE CONCENTRATION; CARDIO-VASCULAR DISEASE; DIABETES MANAGEMENT; NEPHROPATHY; TYPE 1 DIABETES MELLITUS;

BLOOD; GLUCOSE; KETONES; MEDICAL PROBLEMS;

INSULIN;

ARTICLE; ARTIFICIAL PANCREAS; BIOTECHNOLOGY; EQUIPMENT DESIGN; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; HUMAN; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; SYSTEM ANALYSIS;

BIOSENSING TECHNIQUES; BIOTECHNOLOGY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; HUMANS; PANCREAS, ARTIFICIAL; SYSTEMS INTEGRATION;

EID: 77949900203     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2009.935711     Document Type: Article

References (47)

1. L. Jovanovič, "Rationale for prevention and treatment of postprandial glucose-mediated toxicity," Endocrinologist, vol.9, no.2, pp. 87-92, 1999.
2. L. Jovanovič and C. M. Peterson, "Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women," Amer. J. Med., vol.75, pp. 607-612, Oct. 1983.
3. C. M. Peterson, L. Jovanovič, and L. H. Chanoch, "Randomized trial of computer-assisted insulin delivery in patients with type I diabetes beginning pump therapy," Amer. J. Med., vol.81, pp. 69-72, July 1986.
4. E. Dassau, H. Zisser, C. C. Palerm, B. A. Buckingham, L. Jovanovič, and F. J. Doyle, III, "Modular artificial b-cell system: A prototype for clinical research," J. Diab. Sci. Technol., vol.2, no.5, pp. 863-872, 2008.
5. E. Dassau, C. C. Palerm, H. Zisser, B. A. Buckingham, L. Jovanovič, and F. J. Doyle, III, "In silico evaluation platform for artificial pancreatic beta-cell development-A dynamic simulator for closed-loop control with hardware-in-theloop," Diab. Technol. Ther., vol.11, pp. 187-194, Mar. 2009.
6. E. Dassau, H. Zisser, F. J. Doyle, III, and L. Jovanovič, "Sansum/UCSB artificial pancreas software (APS)," Food and Drug Administration, Silver Spring, MA, Master File MAF-1625, 2009.
7. R. Hovorka, "The future of continuous glucose monitoring: Closed loop," Curr. Diab. Rev., vol.4, pp. 269-279, Aug. 2008.
8. R. Hovorka, "Continuous glucose monitoring and closed-loop systems," Diab. Med., vol.23, pp. 1-12, Jan. 2006.
9. U. Fischer, W. Schenk, E. Salzsieder, G. Albrecht, P. Abel, and E. J. Freyse, "Does physiological blood glucose control require an adaptive control strategy?" IEEE Trans. Biomed. Eng., vol.BME-34, no.8, pp. 575-582, 1987.
10. M. W. Percival, H. Zisser, L. Jovanovič, and F. J. Doyle, III, "Closed-loop control and advisory mode evaluation of an artificial pancreatic b-cell: Use of proportional-integral-derivative equivalent model-based controllers," J. Diab. Sci. Technol., vol.2, no.4, pp. 636-644, 2008.
11. P. Dua, F. J. Doyle, III, and E. N. Pistikopoulos, "Multi-objective blood glucose control for type 1 diabetes," Med. Biol. Eng. Comput., vol.47, no.3, pp. 343-352, 2009.
12. E. N. Pistikopoulos, V. Dua, N. A. Bozinis, A. Bemporad, and M. Morari, "On-line optimization via off-line parametric optimization tools," Comput. Chem. Eng., vol.24, no.2-7, p. 188, 2000.
13. P. Dua, F. J. Doyle, III, and E. N. Pistikopoulos, "Model-based blood glucose control for type 1 diabetes via parametric programming," IEEE Trans. Biomed. Eng., vol.53, no.8, pp. 1478-1491, 2006.
14. M. W. Percival, E. Dassau, H. Zisser, L. Jovanovič, and F. J. Doyle, III, "Closed-loop control of an artificial pancreatic beta cell using multi-parametric model predictive control," in Proc. 2008 AIChE Annu. Meeting, Philadelphia, PA, 2008, session 160, paper a.
15. H. Zisser, L. Jovanovič, F. J. Doyle, III, P. Ospina, and C. Owens, "Run-to-run control of meal-related insulin dosing," Diab. Technol. Ther., vol.7, no.1, pp. 48-57, 2005.
16. H. Zisser, C. C. Palerm, W. C. Bevier, F. J. Doyle, III, and L. Jovanovič, "Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm," J. Diab. Sci. Technol., vol.3, no.3, pp. 487-491, 2009.
17. C. C. Palerm, H. Zisser, W. C. Bevier, L. Jovanovič, and F. J. Doyle, III, "Prandial insulin dosing using run-to-run control: Application of clinical data and medical expertise to define a suitable performance metric," Diab. Care, vol.30, pp. 1131-1136, May 2007.
18. Y. Wang, F. Gao, and F. J. Doyle, III, "Survey on iterative learning control, repetitive control, and run-to-run control," J. Process Control, vol.19, no.10, pp. 1589-1600, 2009.
19. Y. Wang, E. Dassau, and F. J. Doyle, III, "Closed-loop control of artificial pancreatic b-cell in type 1 diabetes mellitus using model predictive iterative learning control," IEEE Trans. Biomed. Eng., to be published.
20. Y. Wang, H. Zisser, E. Dassau, L. Jovanovič, and F. J. Doyle, III, "Model predictive control with learning-type reference: Application in artificial pancreatic b-cell," AIChE J., to be published.
21. Y. Wang and F. J. Doyle, III, "Indirect iterative learning control: Application on artificial pancreatic b-cell," in Proc. 21st Chinese Control and Decision Conf., Guilin, China, 2009, pp. 1739-1744.
22. B. P. Kovatchev, C. Breton, C. Dalla Man, and C. Cobelli, "In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes," J. Diab. Sci. Technol., vol.3, no.1, pp. 44-55, 2009.
23. B. P. Kovatchev, D. M. Breton, C. Dalla Man, and C. Cobelli, "In silico model and computer simulation environment approximating the human glucose/insulin utilization," Food Drug Administration, Silver Spring, MA, Master File MAF-1521, 2008.
24. R. N. Bergman, L. S. Phillips, and C. Cobelli, "Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose," J. Clin. Invest., vol.68, pp. 1456-1467, Dec. 1981.
25. R. Hovorka, V. Canonico, L. J. Chassin, U. Haueter, M. Massi-Benedetti, M. O. Federici, T. R. Pieber, H. C. Schaller, L. Schaupp, T. Vering, and M. E. Wilinska, "Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes," Physiol. Meas., vol.25, no.4, pp. 905-920, 2004.
26. M. E. Wilinska, L. J. Chassin, H. C. Schaller, L. Schaupp, T. R. Pieber, and R. Hovorka, "Insulin kinetics in type-I diabetes: Continuous and bolus delivery of rapid acting insulin," IEEE Trans. Biomed. Eng., vol.52, pp. 3-12, Jan. 2005.
27. C. Dalla Man, R. A. Rizza, and C. Cobelli, "Meal simulation model of the glucose-insulin system," IEEE Trans. Biomed. Eng., vol.54, pp. 1740-1749, Oct. 2007.
28. D. A. Finan, H. Zisser, L. Jovanovič, W. C. Bevier, and D. E. Seborg, "Practical issues in the identification of empirical models from simulated type 1 diabetes data," Diab. Technol. Ther., vol.9, pp. 438-450, Oct. 2007.
29. D. A. Finan, F. J. Doyle, III, C. C. Palerm, W. C. Bevier, H. C. Zisser, L. Jovanovič, and D. E. Seborg, "Experimental evaluation of a recursive model identification technique for type 1 diabetes," J. Diab. Sci. Technol., vol.3, no.5, pp. 1192-1202, 2009.
30. E. Dassau, B. W. Bequette, B. A. Buckingham, and F. J. Doyle, III, "Detection of a meal using continuous glucose monitoring (CGM): Implications for an artificial b-cell," Diab. Care, vol.31, no.2, pp. 295-300, 2008.
31. E. Dassau, P. Herrero, H. Zisser, B. A. Buckingham, L. Jovanovič, C. Dalla Man, C. Cobelli, J. Vehí, and F. J. Doyle, III, "Implications of meal library & meal detection to glycemic control of type 1 diabetes mellitus through MPC control," in Proc. 17th IFAC World Congr., Seoul, Korea, 2008, pp. 4228-4233.
32. H. Zisser, L. Robinson, W. Bevier, E. Dassau, C. Ellingsen, F. J. Doyle, III, and L. Jovanovič, "Bolus calculator: A review of four "smart" insulin pumps," Diab. Technol. Ther., vol.10, no.6, pp. 441-444, 2008.
33. C. Ellingsen, E. Dassau, H. Zisser, B. Grosman, M. W. Percival, L. Jovanovič, and F. J. Doyle, III, "Safety constraints in an artificial pancreatic b-cell: An implementation of model predictive control with insulin-on-board," J. Diab. Sci. Technol., vol.3, no.3, pp. 536-544, 2009.
34. The Diabetes Control and Complications Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus," N. Engl. J. Med., vol.329, no.14, pp. 977-986, 1993.
35. E. P. Widmaier, H. Raff, and K. T. Strang, Vander's Human Physiology: The Mechanisms of Body Function, 11th ed. Boston: McGraw-Hill Higher Education, 2008.
36. B. Buckingham, D. M. Wilson, T. Lecher, R. Hanas, K. Kaiserman, and F. Cameron, "Duration of nocturnal hypoglycemia before seizures," Diab. Care, vol.31, pp. 2110-2112, Nov. 2008.
37. E. Dassau, F. M. Cameron, H. Lee, B. W. Bequette, F. J. Doyle, III, G. Niemeyer, P. Chase, and B. Buckingham, "Real-time hypoglycemia prediction using continuous glucose monitoring (CGM), a safety net to the artificial pancreas," in Proc. 68th American Diabetes Association Meeting, San Francisco, CA, 2008, vol.57 (Suppl. 1), p. A13.
38. E. Dassau, F. Cameron, H. Lee, B. W. Bequette, H. Zisser, L. Jovanovič, H. P. Chase, D. M. Wilson, B. A. Buckingham, and F. J. Doyle, III, "Real-time hypoglycemia prediction suite using continuous glucose monitoring (CGM), a safety net for the artificial pancreas," Diab. Care, accepted for publication.
39. E. Dassau, H. Zisser, M. W. Percival, B. Grosman, L. Jovanovič, and F. J. Doyle, III, "Design, validation and clinical evaluation of a fully automated artificial pancreatic b-cell with unannounced meal using mpMPC and IOB," in Proc. 3rd Conf. Advanced Technologies and Treatments for Diabetes, Basel, Switzerland, 2010.
40. E. Dassau, H. Zisser, M. W. Percival, B. Grosman, L. Jovanovič, and F. J. Doyle, III, "Clinical evaluation of fully automated artificial pancreatic b-cell with unannounced meal using mpMPC and insulin-on-board," Diabetes Care, submitted for publication.
41. M. W. Percival, B. Grosman, E. Dassau, H. Zisser, L. Jovanovič, and F. J. Doyle, III, "Automated insulin delivery system demonstrates safe and efficacious control of glycemia," in Proc. 69th American Diabetes Association Meeting, New Orleans, LA, 2009, abstract 3LB.
42. R. Bellazzi, "Telemedicine and diabetes management: Current challenges and future research directions," J. Diab. Sci. Technol., vol.2, no.1, pp. 98-104, 2008.
43. E. Dassau, L. Jovanovič, F. J. Doyle, III, and H. Zisser, "Enhanced 911/GPS wizard: A telemedicine application for the prevention of severe hypoglycemia- Monitor, alert and locate," J. Diab. Sci. Technol., vol.3, no.6, pp. 1501-1506, 2009.
44. D. A. Finan, "Modeling and monitoring strategies for type 1 diabetes," Ph.D. dissertation, Dept. Chem. Eng., UC-Santa Barbara, 2008.
45. M. Breton, "Physical activity-the major unaccounted impediment to closed loop control," J. Diab. Sci. Technol., vol.2, no.1, pp. 169-174, 2008.
46. A. C. Ertl and S. N. Davis, "Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus," Diab. Metab. Res. Rev., vol.20, pp. 124-130, Mar.-Apr. 2004.
47. T. H. Mitchell, G. Abraham, A. Schiffrin, L. A. Leiter, and E. B. Marliss, "Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion," Diab. Care, vol.11, pp. 311-317, Apr. 1988.